← All trials
NCT01248143
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2010
- Primary completion
- Mar 1, 2011
- Completion date
- Mar 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 300
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Touro UniversityLead sponsor
- University of MauritiusCollaborator
- Mauritius Cardiac CenterCollaborator
- Mauritius Ministry of Health and Quality of LifeCollaborator
- Osato Research InstituteCollaborator
- Societe Uniniere de Bois CheriCollaborator
- Mauritius Research CouncilCollaborator
- University of ViennaCollaborator
- Touro UniversityReponsible party - principal investigator
- Touro UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.